HPV Vaccine Awareness, Past Behaviors, and Future Intentions Among a Diverse Sample of Fathers Aged 27 to 45 Years: A National Survey

被引:1
|
作者
Quist, Kevin M. [1 ]
Fontenot, Holly B. [2 ]
Zimet, Gregory [3 ]
Lim, Eunjung [4 ]
Matsunaga, Masako [4 ]
Liebermann, Erica [5 ]
Allen, Jennifer D. [6 ]
机构
[1] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA
[2] Univ Hawaii Manoa, Sch Nursing, Honolulu, HI USA
[3] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA
[4] Univ Hawaii Manoa, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI USA
[5] Univ Rhode Isl, Coll Nursing, Providence, RI USA
[6] Tufts Univ, Sch Arts & Sci, Dept Community Hlth, 574 Boston Ave, Medford, MA 02155 USA
关键词
men's health; cancer prevention; human papillomavirus (HPV); vaccine; attitudes and behaviors; HUMAN-PAPILLOMAVIRUS VACCINE; UNITED-STATES; ACCEPTABILITY; WOMEN; MEN; RECOMMENDATIONS; PREVALENCE; KNOWLEDGE; FEMALES; SEX;
D O I
10.1177/15579883241258823
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Men aged 27 to 45 are eligible for human papillomavirus (HPV) vaccination as of 2019, yet relatively little is known about whether they have received or intend to receive it. We conducted a cross-sectional, online survey among fathers aged 27 to 45 between March and April 2022, to assess associations between HPV vaccination awareness, behaviors, intentions, and psychosocial constructs from the Health Belief Model. We examined the characteristics of those who had (a) heard of the HPV vaccine, (b) already received >= 1 dose, and (c) intentions for future vaccination among those who had never been vaccinated. Among 400 men who completed the survey, 32% were not aware of the HPV vaccine. Among those who were aware, 41% had received >= 1 dose. Sixty-three percent of unvaccinated men reported that they intended to get vaccinated in the future. Multivariable logistic regression analyses revealed that age and race/ethnicity were associated with having been vaccinated previously. Among the unvaccinated, multivariable logistic regression analyses revealed that those with a higher perceived risk of HPV-associated cancer had 3.73 greater odds of reporting they would seek vaccination compared to those with lower perceived risk (95% confidence interval [CI] = [1.28, 12.3]). We did not find perceived benefits, barriers, or decision self-efficacy to be related to future vaccine intentions. Since recommendations for this group include shared clinical decision-making, public health efforts should focus on raising awareness of vaccine eligibility, emphasizing risk factors for HPV-associated cancers so that individuals have an accurate perception of risk, and encouraging conversation between men and their providers.
引用
收藏
页数:13
相关论文
共 36 条
  • [1] HPV vaccine behaviors and intentions among a diverse sample of women aged 27-45 years: implications for shared clinical decision-making
    Allen, Jennifer D.
    Abuelezam, Nadia N.
    Rose, Raviv
    Isakoff, Katelin
    Zimet, Gregory
    Fontenot, Holly B.
    [J]. BMC PUBLIC HEALTH, 2024, 24 (01)
  • [2] Awareness and knowledge of HPV and HPV vaccination among adults ages 27-45 years
    Thompson, Erika L.
    Wheldon, Christopher W.
    Rosen, Brittany L.
    Maness, Sarah B.
    Kasting, Monica L.
    Massey, Philip M.
    [J]. VACCINE, 2020, 38 (15) : 3143 - 3148
  • [3] COVID-19 vaccine behaviors and intentions among a national sample of United States adults ages 18-45
    Brownstein, Naomi C.
    Reddy, Harika
    Whiting, Junmin
    Kasting, Monica L.
    Head, Katharine J.
    Vadaparampil, Susan T.
    Giuliano, Anna R.
    Gwede, Clement K.
    Meade, Cathy D.
    Christy, Shannon M.
    [J]. PREVENTIVE MEDICINE, 2022, 160
  • [4] Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years
    Maldonado, Ivette
    Plata, Manuel
    Gonzalez, Mauricio
    Correa, Alfonso
    Nossa, Claudia
    Giuliano, Anna R.
    Joura, Elmar A.
    Ferenczy, Alex
    Ronnett, Brigitte M.
    Stoler, Mark H.
    Zhou, Hao Jin
    Joshi, Amita
    Das, Rituparna
    Bautista, Oliver
    Group, Thomas
    Luxembourg, Alain
    Saah, Alfred
    Buchwald, Ulrike Kirsten
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [5] Correlates of HPV Vaccination Intentions Among Adults Ages 27-45 Years Old in the US
    Thompson, Erika L.
    Garg, Ashvita
    Galvin, Annalynn M.
    Moore, Jonathan D.
    Kasting, Monica L.
    Wheldon, Christopher W.
    [J]. JOURNAL OF COMMUNITY HEALTH, 2021, 46 (05) : 893 - 902
  • [6] Demographic and High-Risk Behaviors associated with HPV and HPV Vaccine Awareness among Persons Aged 15-74 Years in Puerto Rico
    Reyes, Juan Carlos
    Sanchez-Diaz, Carola T.
    Tortolero-Luna, Guillermo
    Colon, Hector M.
    Ortiz, Ana Patricia
    [J]. PUERTO RICO HEALTH SCIENCES JOURNAL, 2015, 34 (04) : 195 - 200
  • [7] DISPARITIES IN KNOWLEDGE AND AWARENESS OF HPV AND HPV VACCINE DETECTED AMONG DIFFERENT RACE GROUPS AND GENDER IN A NATIONAL SAMPLE
    Boakye, Eric Adjei
    Tobo, Betelihem B.
    Rojek, Rebecca P.
    Osazuwa-Peters, Nosayaba
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S109 - S109
  • [8] Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years
    Rincon, Natalie L.
    McDowell, Kelsey Rae
    Weatherspoon, Darien
    Ritchwood, Tiarney D.
    Rocke, Daniel J.
    Boakye, Eric Adjei
    Osazuwa-Peters, Nosayaba
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [9] Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among adults aged 27-45 years in the United States
    Osazuwa-Peters, Nosayaba
    Rincon, Natalie
    McDowell, Kelsey Rae
    Ritchwood, Tiarney
    Boakye, Eric Adjei
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [10] Correlates of HPV Vaccination Intentions Among Adults Ages 27–45 Years Old in the U.S.
    Erika L. Thompson
    Ashvita Garg
    Annalynn M. Galvin
    Jonathan D. Moore
    Monica L. Kasting
    Christopher W. Wheldon
    [J]. Journal of Community Health, 2021, 46 : 893 - 902